Compare CYTK & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | FLS |
|---|---|---|
| Founded | 1997 | 1790 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.1B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | FLS |
|---|---|---|
| Price | $62.50 | $77.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 10 |
| Target Price | ★ $82.38 | $77.10 |
| AVG Volume (30 Days) | ★ 2.2M | 1.0M |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | N/A | ★ 69.42 |
| EPS | N/A | ★ 3.44 |
| Revenue | $87,211,000.00 | ★ $4,687,417,000.00 |
| Revenue This Year | $339.72 | $5.69 |
| Revenue Next Year | $79.08 | $3.92 |
| P/E Ratio | ★ N/A | $22.44 |
| Revenue Growth | ★ 2609.26 | 3.19 |
| 52 Week Low | $29.31 | $37.34 |
| 52 Week High | $70.98 | $77.54 |
| Indicator | CYTK | FLS |
|---|---|---|
| Relative Strength Index (RSI) | 47.75 | 72.25 |
| Support Level | $60.30 | $73.44 |
| Resistance Level | $65.08 | $73.55 |
| Average True Range (ATR) | 2.91 | 1.40 |
| MACD | -0.01 | 0.44 |
| Stochastic Oscillator | 45.74 | 94.09 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.